Trial Condition(s):

Vaginal yeast infections

Activity and tolerability of BAY b 5097 500mg vaginal tablets in single dose or one day treatment of vaginal Candida infections

Bayer Identifier:

Trial_0475

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
100
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information